Literature DB >> 6341195

Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease.

P Kurki, A Miettinen, M Salaspuro, I Virtanen, S Stenman.   

Abstract

Antibodies to cytoplasmic microfilaments, intermediate filaments (vimentin filaments), and microtubules which comprise the cytoskeleton of the cell were assayed in sera from 23 patients with HBsAg-negative chronic active hepatitis and 1 with HBsAg-positive chronic active hepatitis, 15 patients with primary biliary cirrhosis, 20 patients with alcoholic liver disease, and 32 healthy controls. The cytoskeleton antibodies were assayed by indirect immunofluorescence technique using vinblastine-treated cultured human embryonic fibroblasts as substrates. There was a significantly increased incidence of cytoskeleton antibodies in patients with liver disease as compared to the control group. Antibodies to microfilaments were found frequently in sera from patients with chronic active hepatitis (67%) and primary biliary cirrhosis (53%) but were rare in sera from patients with alcoholic liver disease (25%) and in control sera (3%). On the other hand, antibodies to microtubules were found in 50% of sera from patients with alcoholic liver disease but in only 7 to 13% of sera from other groups. Intermediate filament antibodies of IgG or IgA class were found only in patient sera whereas intermediate filament antibodies of IgM class were found in the majority of sera in all groups including control sera. The highest titers of intermediate filament antibodies were seen in primary biliary cirrhosis and chronic active hepatitis. The production of cytoskeleton antibodies may be due to the reorganization or destruction of cytoskeletal structures in the liver.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341195     DOI: 10.1002/hep.1840030304

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Antibodies to neurofilament protein in retinitis pigmentosa.

Authors:  G M Galbraith; D Emerson; H H Fudenberg; C J Gibbs; D C Gajdusek
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

Review 2.  Autoantibodies in primary biliary cirrhosis.

Authors:  P A Berg; R Klein
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Liver cell shedding and phagocytic reaction in alcoholic liver disease. An ultrastructural study.

Authors:  K A Bardadin; P J Scheuer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  Autoimmunity in chronic liver disease caused by hepatitis delta virus.

Authors:  D Zauli; C Crespi; F B Bianchi; A Craxi; E Pisi
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

5.  Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.

Authors:  N Dobashi; J Fujita; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Kamei; M Tokuda; S Hojo; H Okada; J Takahara
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 6.  Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

7.  Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases.

Authors:  C A von Mühlen; E K Chan; C L Peebles; H Imai; K Kiyosawa; E M Tan
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

8.  Distribution of the PBC-specific- (M2) and the naturally-occurring mitochondrial antigen- (NOMAg) systems in plants.

Authors:  P Lang; R Klein; E W Becker; P A Berg
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

9.  A confocal microscopy study of anticytoskeletal antibody activity in patients with connective tissue disease.

Authors:  P W French; R Penny; J L Yang
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

10.  Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis.

Authors:  Andrew J Kinloch; Matthew D Cascino; Jian Dai; Rene S Bermea; Kichul Ko; Margaret Vesselits; Leonard L Dragone; Nirit Mor Vaknin; Maureen Legendre; David M Markovitz; Michael K Okoreeh; Michael J Townsend; Marcus R Clark
Journal:  Lupus       Date:  2020-03-26       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.